×

Controlled substance tracking system and method

  • US 7,970,622 B2
  • Filed: 03/18/2004
  • Issued: 06/28/2011
  • Est. Priority Date: 11/14/2001
  • Status: Active Grant
First Claim
Patent Images

1. A pharmaceutical information control system comprising:

  • an entity database associated with each of a plurality of entities, networks and organizations at various points within the prescriptive medication process of controlled substances that maintain databases of pharmaceutical data including prescription drug use data, each database having a format that provides for access control and management capabilities for individual users as dictated by each of the plurality of entities, networks and organizations, legislation or a combination thereof,wherein the plurality of entities, networks and organizations comprise doctors, affiliated pharmacies, unaffiliated pharmacies, hospitals, pharmaceutical companies, insurance companies, government agencies, health care informatics companies, health researchers, managed care organizations, healthcare providers and combinations thereof,a data storage device for accessing the entity database of the plurality of entities, networks and organizations and storing entity information,application programming interfaces and service components to enable the integration of an entity system, wherein the application programming interfaces and service components support industry standards,wherein the application programming interfaces and service components provide managed access and sharing of contextually relevant information from the plurality of entities, networks and organizations and provide business logic and workflow for the contextual management, collection, assembly, reporting, alerting, sharing or a combination thereof of information consistent with availability and satisfying legislative and corporate requirements and standards for data management, entity security, integration needs or combinations thereof,an information access filter for changing the format of the data between the data format used by the entity database and the format used by the data storage device for selecting pharmaceutical data for creating a complete prescriptive history of an individual, and for maintaining the privacy of information related to the individual,wherein the data storage device is adapted for communication with the information access filter and the application program interfaces and service components, for analyzing the information in the data storage device and providing analysis thereof to the application program interfaces and service components,wherein the application programming interfaces and service components are in operative association with the data storage device, the entity database and a login authentication system for validating the access of the user and for the user to request a pharmaceutical transaction, wherein the pharmaceutical transaction is communicated to the data storage device for storage,and wherein the data storage device is adapted to acquire the entity information and prior pharmaceutical transactions related to the pharmaceutical transaction, thereby acquiring an updated complete prescriptive history including active and inactive prescriptive medications related to the current pharmaceutical transaction and analyzing the updated complete prescriptive history by generating one or more patterns that detect prescription duplication or multi-source prescription abuse for providing at least one of;

    the analysis of the information, or a recommendation to the graphical user interface, thereby recommending the approval of the pharmaceutical transaction, the declination of the pharmaceutical transaction application of notes, comments or flags to the pharmaceutical transaction or a combination thereof.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×